Clinical Trial Update: An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures [Phase 2]

View source ↗

Summary

An open-label Phase 2 trial to evaluate the efficacy and safety of PRAX-628 in adults with focal onset seizures or primary generalized epilepsy, currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Focal Onset Seizures
• Generalized Epilepsy

Drugs mentioned

• PRAX-628

Snippet

Sponsor: Praxis Precision Medicines | Conditions: Focal Onset Seizure, Primary Generalized Epilepsy | Phase 2 | Status: RECRUITING